Protara Therapeutics Cash from Investing (TTM) Analysis

Protara Therapeutics Inc (TARA)

2.91 +0.02 (+0.69%) USD | NASDAQ | May 03, 16:00

2.89 -0.02 (-0.69%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	53.11M
September 30, 2023	20.24M
June 30, 2023	32.91M
March 31, 2023	24.06M
December 31, 2022	14.95M
September 30, 2022	35.18M
June 30, 2022	16.24M

Date	Value
March 31, 2022	0.80M
December 31, 2021	-98.19M
September 30, 2021	-100.59M
June 30, 2021	-100.83M
March 31, 2021	-98.89M
December 31, 2020	2.835M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-100.83M

Minimum

Jun 2021

53.11M

Maximum

Dec 2023

-15.24M

Average

14.95M

Median

Dec 2022

Cash from Investing (TTM) Benchmarks